A novel missense mutation in F9 gene causes hemophilia B in a family with clinical variability.

: Hemophilia B is an X-linked recessive bleeding disorder caused by diverse mutations throughout the F9 gene. The same F9 mutation may result in different degrees of clotting factor deficiency. The aim of this study was to investigate the pathogenesis of two hemophilia B patients with different severity in a family. A family with two hemophilia B patients was recruited in this study. Coagulation assays, activities of FVIII (FVIII:C) and FIX (FIX:C) were evaluated. All of the exons and intron exon boundaries of the F9 gene were amplified by PCR and analyzed by direct sequencing. The proband, 12-year-old boy with moderate bleeding history, had manifest prolonged activated partial thromboplastin time (98.1 s) and markedly decreased FIX activity (1%). His maternal uncle presented slightly prolonged activated partial thromboplastin time (48.2 s) and mildly decreased FIX activity (15.2%). Molecular genetic analysis of F9 revealed that they were hemizygous for a novel missense mutation, c.157G>C (p.Glu53Gln). Our study widens the mutation spectrum of the FIX gene. In addition, this report provides a specific case associated with genotype and phenotype heterogeneity of hemophilia B.

[1]  X. Qin,et al.  Comprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  S. Perkins,et al.  An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B , 2013, Journal of thrombosis and haemostasis : JTH.

[3]  A. Goodeve,et al.  Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B , 2012, Thrombosis and Haemostasis.

[4]  A. Bitonti,et al.  Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. , 2012, Blood.

[5]  L. Aledort Optimizing the treatment of haemophilia B: laboratory and clinical perspectives , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  S. Chavali,et al.  Hemophilia B is a quasi-quantitative condition with certain mutations showing phenotypic plasticity. , 2009, Genomics.

[7]  Amitabh Sharma,et al.  Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IX , 2008, Proteins.

[8]  A. Srivastava,et al.  The phenotypic heterogeneity of severe hemophilia. , 2008, Seminars in thrombosis and hemostasis.

[9]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[10]  K. Fischer,et al.  Phenotype of severe hemophilia A and plasma levels of risk factors for thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.

[11]  D. Stafford The vitamin K cycle , 2005, Journal of thrombosis and haemostasis : JTH.

[12]  V. Blanchette,et al.  The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. , 2005, Blood.

[13]  B. Furie,et al.  Crystal Structure of the Calcium-stabilized Human Factor IX Gla Domain Bound to a Conformation-specific Anti-factor IX Antibody* , 2004, Journal of Biological Chemistry.

[14]  K. Pasi,et al.  Haemophilias A and B , 2003, The Lancet.

[15]  M. Griesshammer,et al.  Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  C. Kessler,et al.  Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates. , 2001, Blood.

[17]  E. Beutler,et al.  Perspectives (145 articles) , 2013 .

[18]  M. Goossens,et al.  Haemophilia B (sixth edition): a database of point mutations and short additions and deletions , 1996, Nucleic Acids Res..

[19]  K. Kurachi,et al.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.